- Home
- ORIS vs SLGL Comparison
ORIS vs SLGL Comparison
Compare ORIS & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIS
- SLGL
- Stock Information
- Founded
- ORIS 2014
- SLGL 1997
- Country
- ORIS China
- SLGL Israel
- Employees
- ORIS N/A
- SLGL N/A
- Industry
- ORIS Farming/Seeds/Milling
- SLGL Biotechnology: Pharmaceutical Preparations
- Sector
- ORIS Consumer Staples
- SLGL Health Care
- Exchange
- ORIS Nasdaq
- SLGL Nasdaq
- Market Cap
- ORIS 19.5M
- SLGL 21.1M
- IPO Year
- ORIS 2024
- SLGL 2018
- Fundamental
- Price
- ORIS $0.87
- SLGL $7.24
- Analyst Decision
- ORIS
- SLGL Buy
- Analyst Count
- ORIS 0
- SLGL 1
- Target Price
- ORIS N/A
- SLGL $40.00
- AVG Volume (30 Days)
- ORIS 974.4K
- SLGL 13.2K
- Earning Date
- ORIS 02-21-2025
- SLGL 05-23-2025
- Dividend Yield
- ORIS N/A
- SLGL N/A
- EPS Growth
- ORIS N/A
- SLGL N/A
- EPS
- ORIS 0.17
- SLGL N/A
- Revenue
- ORIS $15,014,000.00
- SLGL $12,103,000.00
- Revenue This Year
- ORIS N/A
- SLGL N/A
- Revenue Next Year
- ORIS N/A
- SLGL $31.17
- P/E Ratio
- ORIS $5.12
- SLGL N/A
- Revenue Growth
- ORIS N/A
- SLGL 603.66
- 52 Week Low
- ORIS $0.82
- SLGL $3.34
- 52 Week High
- ORIS $56.01
- SLGL $16.50
- Technical
- Relative Strength Index (RSI)
- ORIS N/A
- SLGL 50.26
- Support Level
- ORIS N/A
- SLGL $7.15
- Resistance Level
- ORIS N/A
- SLGL $7.45
- Average True Range (ATR)
- ORIS 0.00
- SLGL 0.32
- MACD
- ORIS 0.00
- SLGL -0.10
- Stochastic Oscillator
- ORIS 0.00
- SLGL 31.36
About ORIS Oriental Rise Holdings Limited Ordinary Shares
Oriental Rise Holdings Ltd is an integrated supplier of tea products in China. It is principally engaged in the business of planting, cultivating, processing, and selling processed tea. The company currently produces and sells three categories of products: roughly processed white tea, roughly processed black tea, and refined tea. The company's business operations are vertically integrated, covering cultivation, processing of tea leaves, and the sale of tea products to tea business operators and end-user retail customers. Geographically, the company generates all of its revenue from its business in the People's Republic of China (the PRC).
About SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.